Strategic Channel Boston Scientific's acquisition of Ablacon positions Cortex within a major medtech ecosystem, creating a ready-made channel to co-sell AI-based AF diagnosis and electrophysiology mapping solutions to hospitals and labs.

AF Mapping Fit The real-time high-precision AI-based AF diagnosis system can be integrated into electrophysiology workflows, offering a compelling upgrade to existing mapping and ablation platforms.

Lean Deployment A small, agile team enables rapid pilots and fast validation in clinical settings, especially when supported by a large corporate partner for deployment and scale.

Clinical Credibility A strong clinical advisory board and experienced leadership provide credibility for multicenter studies and evidence generation, accelerating customer adoption and payer discussions.

Investment Momentum Ongoing funding activity and continuous product updates signal momentum that can fuel joint development, regulatory clearance, and broader adoption across hospital networks.